Michael F. Huang

Sr. VP of Clinical Development · 3 filings · Latest: May 18, 2026

SOLENO THERAPEUTICS INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SLNO	Michael F. Huang	Sr. VP of Clinical Development	Mar 27, 2026	Sale	$30.44	6,582	$200.4K	39,823	Apr 1 12:15 AM
SLNO	Michael F. Huang	—	Mar 27, 2025	Proposed Sale	$50.05	29,625	$1.5M	—	Mar 27 12:55 PM